Stay updated on Efruxifermin in NASH Subjects Clinical Trial
Sign up to get notified when there's something new on the Efruxifermin in NASH Subjects Clinical Trial page.

Latest updates to the Efruxifermin in NASH Subjects Clinical Trial page
- Check2 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 with no visible changes to study details, contacts, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check9 days agoChange DetectedAdded related topics: Non-alcoholic fatty liver disease and MedlinePlus Genetics to the page to provide broader context and links to background information.SummaryDifference0.1%

- Check16 days agoChange DetectedRemoved the topic 'Non-alcoholic fatty liver disease' and related topic 'MedlinePlus Genetics' from the page's related topics. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check24 days agoChange DetectedAdded 'Non-alcoholic fatty liver disease' to the MedlinePlus Genetics related topics. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check31 days agoChange DetectedAdded a consolidated Locations section listing site locations across Arizona, Arkansas, California, Florida, Louisiana, Missouri, New Jersey, Tennessee, and Texas and updated the revision to v3.3.3; removed the prior separate state-location entries and some related topics (MedlinePlus Genetics, Non-alcoholic fatty liver disease, HHS Vulnerability Disclosure).SummaryDifference1%

- Check45 days agoChange DetectedAdded related topics links for Non-alcoholic fatty liver disease and MedlinePlus Genetics to the page navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Efruxifermin in NASH Subjects Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efruxifermin in NASH Subjects Clinical Trial page.